Canton Strategic Holdings (CNTN) Cash from Investing Activities (2026)

Canton Strategic Holdings (CNTN) posted Cash from Investing Activities of -$54.8 million for Q1 2026.

Canton Strategic Holdings (CNTN) Cash from Investing Activities (2026) Analysis & Trends

Canton Strategic Holdings' Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$54.8 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn - -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn - -
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.74 Bn 62.74 Bn - -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn -25.54 Mn
10 Canton Strategic Holdings 430.99 Mn 430.99 Mn - -54.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -54.82 Mn
Mar 31, 2026 -54.82 Mn